Greg Stanton Stock Trades

Almost every transaction disclosed under Rep. Greg Stanton's name falls in 2023. Of the 191 transactions in the disclosure record, 188 were recorded that year: 94 purchases and 94 sales, all attributed to a spouse. The supplied detailed rows include a broad run of sales dated October 24, 2023, while the most frequently disclosed securities list reports that date as the latest transaction date for every name shown. That dense period of activity, rather than a pattern repeated every year, defines this record. Before it, there was one transaction in 2022. The record then shows no transactions in 2024 or 2025 before two partial sales appeared in 2026.

Every one of the 191 transactions in the disclosure history carries the "Spouse" attribution code. None are attributed to Stanton personally, jointly, to a dependent child, or to an unknown filer. That is a meaningful distinction for anyone reading this record as a signal of the congressman's own market views: what appears here is spouse-attributed activity, not activity attributed to Stanton himself.

The 2023 Trading Activity

During 2023, the spouse-attributed activity covered dozens of familiar public companies. Teledyne Technologies (TDY) appears most often in the supplied transaction-frequency list, with three total transactions: one purchase and two sales. Just behind it is a long list of names appearing twice each, with one purchase and one sale apiece, among them Apple, AbbVie, Abbott Laboratories, Accenture, Adobe, Analog Devices, Applied Materials, AMD, Amgen, Amazon, Broadcom, Axon Enterprise, American Express, Bank of America, Ball Corporation, Becton Dickinson, BlackRock, Bristol-Myers Squibb, Berkshire Hathaway Class B, Citigroup, Caterpillar, Chubb, Comcast, ConocoPhillips, and other companies spanning technology, health care, financials, energy, industrials, and consumer sectors. Among the detailed October 24 transaction rows, the Apple and Microsoft sales were each disclosed in the $15,001-$50,000 range, while many of the other supplied sales were reported in the $1,001-$15,000 range. Those figures are disclosure bands rather than exact transaction values.

The sector breakdown of the full 191-transaction record reflects that breadth. Information Technology leads with 42 transactions, followed by Health Care (38), Financials (28), Communication Services (18), Industrials (17), Consumer Discretionary (16), Consumer Staples (14), Energy (6), Materials (4), an Unknown-sector bucket (4), and Real Estate and Utilities tied at 2 each. Technology and health care account for the two largest categories, but the disclosed activity extends across every sector category supplied in the packet. The data establish a broad sector mix without establishing why any particular purchase or sale occurred.

Several of the most frequently disclosed names are major businesses in their respective sectors. Teledyne Technologies supplies digital imaging products, instrumentation, aerospace and defense electronics, and engineered systems. Accenture's supplied company profile covers strategy and consulting, technology, operations, and related services, while IBM's business spans software, consulting, infrastructure, and financing. AbbVie and Amgen are biopharmaceutical companies classified in Health Care. BlackRock and Goldman Sachs represent asset management and broader financial services, while Bank of America and Citigroup provide banking and related financial products. Apple and Microsoft are both classified as Information Technology companies in the packet, and their supplied October 24 sale rows fall in the $15,001-$50,000 disclosure band.

A Long Gap, Then Two Trulieve Partial Sales

Following the 2023 activity, the disclosure history shows nothing in 2024 or 2025. The next transactions appeared in 2026, when the spouse-attributed activity included two partial sales of Trulieve Cannabis Corp (TCNNF). The first was a transaction dated May 6, 2026, disclosed on May 7 in the $15,001-$50,000 range. The second was dated May 28, disclosed on June 26, and fell in the $100,001-$250,000 range. Both are labeled "Sale (Partial)" and both carry the "Spouse" attribution code. The packet does not identify Trulieve's sector, industry, or business description, so this profile goes no further than the supplied company name, ticker, transaction type, dates, attribution, and disclosed dollar ranges.

Taken together, the record shows infrequent but occasionally dense activity. It contains one sale in 2022, 188 transactions in 2023, no transactions in 2024 or 2025, and two partial sales in 2026. The 2023 totals are evenly divided between 94 purchases and 94 sales. Within the supplied transaction-frequency list, Teledyne leads with three entries, while every other listed security has two, one purchase and one sale. The two most recent entries concern the same ticker, TCNNF, and are both spouse-attributed partial sales.

About this profile

This profile is built from official congressional financial disclosure filings, required under the Stop Trading on Congressional Knowledge Act of 2012 and administered per the House Committee on Ethics financial disclosure instruction guide. All 191 transactions referenced here are attributed to a spouse, not to Rep. Stanton personally, per the source filings, including the filing covering much of the October 2023 activity, a related 2023 filing, and the two filings covering the May 6, 2026 transaction and the May 28, 2026 transaction. Dollar amounts reflect disclosed reporting ranges rather than exact transaction values. No Quantellect Score is published for this member as of the latest scoring date, August 21, 2026. This profile reflects publicly disclosed information only and is not investment advice.